We are live on ! Find out more
NED

Nancy E. Dempze Portfolio holdings

AUM $182M
1-Year Est. Return 16.09%
This Fund
S&P 500
This Quarter Est. Return
+6.15%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$182M
AUM Growth
+$8.69M
Cap. Flow
-$141K
Cap. Flow %
-0.08%
Top 10 Hldgs %
38.63%
Holding
93
New
1
Increased
24
Reduced
30
Closed
7

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.14M
2
LLY icon
Eli Lilly
LLY
+$925K
3
AMAT icon
Applied Materials
AMAT
+$857K
4
AXP icon
American Express
AXP
+$509K
5
UBER icon
Uber
UBER
+$424K

Sector Composition

Rank Sector Weight
1 Technology 28.52%
2 Healthcare 16.53%
3 Industrials 12.9%
4 Financials 9.91%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
76
Novo Nordisk
NVO
$228B
-14,678
Closed -$1.01M

Similar funds

Nancy E. Dempze's Q3 2025 Portfolio in Review

As of Q3 2025, Nancy E. Dempze held 93 positions worth $182M, up 5% from $173M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Nancy E. Dempze's Q3 2025 filing shows 1 new, 24 increased, 30 reduced and 7 closed positions. Its largest new stake was Sprott Gold Miners ETF: 3,250 shares worth $202K. The largest sale was Novo Nordisk, an estimated $1.01M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Nancy E. Dempze's largest Q3 2025 buy was Sprott Gold Miners ETF: 3,250 shares worth $202K.
  • Nancy E. Dempze added most to UnitedHealth in Q3 2025, an estimated $1.14M increase.
  • Nancy E. Dempze's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $672K.
  • Nancy E. Dempze fully exited Novo Nordisk in Q3 2025, selling an estimated $1.01M.
  • Nancy E. Dempze's ten largest holdings make up 39% of its $182M portfolio in Q3 2025.
  • Nancy E. Dempze opened 1 new position and closed 7 in Q3 2025.
  • Nancy E. Dempze's portfolio value rose 5% quarter-over-quarter to $182M.

Based on Nancy E. Dempze's 13F filing for Q3 2025, filed 10 Nov 2025.